TKI (Tyrosine Kinase Inhibitor) Intermediates
High-Quality TKI Intermediates for Research and Drug Development
Zhejiang ShiLai Bioengineering Co., Ltd. provides a comprehensive range of high-purity TKI intermediates, including EGFR, ALK, BTK, MET, and RET inhibitor intermediates. Our intermediates are produced under strict quality control standards, ensuring consistent purity, reliable batch-to-batch performance, and suitability for R&D and API synthesis.